Dr. Nader Khalidi

Nader A. Khalidi

MD, FRCPC, FACP, FACR

Associate Professor, Division of Rheumatology, Department of Medicine

Program Director, Rheumatology Residency Program

Staff Rheumatologist, St. Joseph's Healthcare Hamilton

 

 

 

Education and Professional Standing

Dr. Nader Khalidi is an Associate Professor in the Department of Medicine and rheumatologist at McMaster University in Hamilton, Ontario, Canada.  He is currently the Program Director for Rheumatology Residency Program and is Head of Service for Rheumatology at St. Joseph’s Healthcare in Hamilton, Ontario.

Dr. Khalidi has a strong interest in Vasculitis. He is a Co-Investigator and Steering Committee Member of the Vasculitis Clinic Research Consortium (VCRC) and recruits patients for its North American Database that includes the University of Toronto and many US sites such as Boston University, Cleveland Clinics, University of Pennsylvania and the Mayo Clinic. He is involved in numerous international research projects in Vasculitis as part of the VCRC. He runs a Vasculitis clinic at St. Joseph’s Healthcare. He is currently also involved in local research to assess the role of MRI of temporal arteries versus temporal artery biopsy in Giant Cell Arteritis as well as many other clinical research projects.

He has been involved with the Canadian Scleroderma Research Study Group (CSRG) along with its database and is actively recruiting patients for the national database since 2007.  He has been involved in numerous local and national research projects in Scleroderma as part of the CSRG.  He is an executive member of the Hamilton Scleroderma Group that strives for excellence in research and education in Scleroderma in Hamilton and its surrounding areas in particular.

Selected Publications

  1. Rhéaume M, Rebello R, Pagnoux C, Carette S, Clements-Baker M, Cohen-Hallaleh V, Doucette-Preville D, Stanley Jackson B, Salama Sargious Salama S, Ioannidis G, Khalidi NA.(2017). High-Resolution Magnetic Resonance Imaging of Scalp Arteries for the Diagnosis of Giant Cell Arteritis: Results of a Prospective Cohort Study.Arthritis Rheumatol. 69(1): 161-168.
  2. Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL, Sreih AG, Spiera R, McAlear CA, Warrington KJ, Pagnoux C, McKinnon K, Forbess LJ, Hoffman GS, Borchin R, Krischer JP, Merkel PA; Vasculitis Clinical Research Consortium..(2017). A randomized, double-blind trial of abatacept (CTLA4-ig) for the treatment of takayasu'sarteritis. Arthritis Rheumatol.
  3. Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, Seo P, Moreland LW, Weisman M, Koening CL, Sreih A, Spiera R, McAlear CA, Warrington KJ, Pagnoux C, McKinnon K, Forbess LJ, Hoffman GS, Borchin R, Krischer JP, Merkel PA; Vasculitis Clinical Research Consortium.. (2017). A randomized, double-blind trial of abatacept (CTLA4-IG) for the treatment of giant cell arteritis. Arthritis Rheumatol.
  4. Mukherjee M, Lim HF, Thomas S, Miller D, Kjarsgaard M, Tan B, Sehmi R, Khalidi N, Nair P.(2017). Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy. Allergy Asthma Clin Immunol.13(2)
  5. Richard N, Hudson M, Gyger G, Baron M, Sutton E, Khalidi N, Pope JE, Carrier N, Larché M, Albert A, Fortin PR, Thorne C, Masetto A; on the behalf of Canadian Scleroderma Research Group. (2016). Clinicalcorrelates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues. Rheumatology (Oxford).
  6. Levis AW, Harel D, Kwakkenbos L, Carrier ME, Mouthon L, Poiraudeau S, Bartlett SJ, Khanna D, Malcarne VL, Sauve M, van den Ende CH, Poole JL, Schouffoer AA, Welling J, Thombs BD; and the Scleroderma Patient-Centered Intervention Network Investigators..(2016). Using Optimal Test Assembly Methods for Shortening Patient-Reported Outcome Measures: Development and Validation of the Cochin Hand Function Scale-6: A Scleroderma Patient-Centered Intervention Network Cohort Study. Arthritis Care Res (Hoboken). 68(11): 1704-1713.
  7. Merkel PA, Xie G, Monach PA, Ji X, Ciavatta DJ, Byun J, Pinder BD, Zhao A, Zhang J, Tadesse Y, Qian D, Weirauch M, Nair R, Tsoi A, Pagnoux C, Carette S, Chung S, Cuthbertson D, Davis JC Jr, Dellaripa PF, Forbess L, Gewurz-Singer O, Hoffman GS, Khalidi N, Koening C, Langford CA, Mahr AD, McAlear C, Moreland L, Seo EP, Specks U, Spiera RF, Sreih A, St Clair EW, Stone JH, Ytterberg SR, Elder JT, Qu J, Ochi T, Hirano N, Edberg JC, Falk RJ, Amos CI, Siminovitch KA; Vasculitis Clinical Research Consortium.. (2016). Identification of functional and expression polymorphisms associated with risk for anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Arthritis Rheumatol. 2016 Dec 28.
  8. Kermani TA, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, McKinnon- Maksimowicz K, McAlear CA, Monach PA, Seo P, Warrington KJ, Ytterberg SR, Merkel PA, Matteson EL. (2016). The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell Arteritis.J Rheumatol.43(6): 1078-84.
  9. Baron M, Pope J, Robinson D, Jones N, Khalidi N, Docherty P, Kaminska E, Masetto A, Sutton E, MathieuJP, Ligier S, Grodzicky T, LeClercq S, Thorne C, Gyger G, Smith D, Fortin PR, Larché M, Abu-HakimaM, Rodriguez-Reyna TS, Cabral-Castaneda AR, Fritzler MJ, Wang M, Hudson M.(2016). Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study.Rheumatology (Oxford). 55(12): 2148-2155.
  10. Khanna D, Albera C, Fischer A, Khalidi N, Raghu G, Chung L, Chen D, Schiopu E, Tagliaferri M, Seibold JR, Gorina E.(2016). An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial.J Rheumatol. 43(9): 1672-9.
  11. Alsolaimani RS, Bhavsar SV, Khalidi NA, Pagnoux C, Mandzia JL, Tay K, Barra LJ.(2016). Severe Intracranial Involvement in Giant Cell Arteritis: 5 Cases and Literature Review.J Rheumatol.43(3): 648-56.
  12. Cividino A, Bakowsky V, Barr S, Bessette L, Hazel E, Khalidi N, Pope J, Robinson D, Shojania K, Yacyshyn E, Lohfeld L, Crawshaw D.(2016). How to Attract Trainees, a Pan-Canadian Perspective: Phase 1 of the “Training the Rheumatologists of Tomorrow” Project.J Rheumatol.43(4): 788-98.